Investing in Accuray Incorporated (ARAY)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/a
Intrinsic value (DCF)0.00-100
Graham-Dodd Method0.00-100
Graham Formula0.00-100

Company description

Accuray Inc. (ARAY) is a global medical technology company that designs, manufactures, and sells radiation oncology treatment systems for cancer patients. The company was founded in 1990 and is headquartered in Sunnyvale, California. They have a strong presence in both the domestic and international markets, with customers in over 40 countries worldwide. The company's flagship product, the CyberKnife System, is a non-invasive robotic radiosurgery system that delivers precise radiation treatment to tumors. Additionally, they offer the TomoTherapy System, which combines advanced image-guidance and intensity-modulated radiation therapy to provide personalized treatment for a wide range of cancer types. With a commitment to innovation and improving cancer care, Accuray continues to collaborate with leading clinicians and institutions to advance their technology and make a positive impact on patients' lives. They also provide comprehensive service and maintenance plans to ensure their systems are running optimally for their customers. Despite facing strong competition in the radiation therapy market, Accuray has established a solid reputation for their quality products and commitment to oncology treatment. They are constantly developing new technologies and expanding their product offerings to meet the evolving needs of the healthcare industry. Overall, Accuray is a highly reputable and innovative company that is dedicated to improving the lives of cancer patients around the world.